CGS-12970

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCGS-12970
Drug Alias NameCGS-12970
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsThromboxane A2 synthase
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A